Global Innovative Biologics and Biosimilars Supply, Demand and Key Producers, 2023-2029
The global Innovative Biologics and Biosimilars market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
This report studies the global Innovative Biologics and Biosimilars demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Innovative Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Innovative Biologics and Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Innovative Biologics and Biosimilars total market, 2018-2029, (USD Million)
Global Innovative Biologics and Biosimilars total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Innovative Biologics and Biosimilars total market, key domestic companies and share, (USD Million)
Global Innovative Biologics and Biosimilars revenue by player and market share 2018-2023, (USD Million)
Global Innovative Biologics and Biosimilars total market by Type, CAGR, 2018-2029, (USD Million)
Global Innovative Biologics and Biosimilars total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Innovative Biologics and Biosimilars market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Innovative Biologics and Biosimilars market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Innovative Biologics and Biosimilars Market, By Region:
1. How big is the global Innovative Biologics and Biosimilars market?
2. What is the demand of the global Innovative Biologics and Biosimilars market?
3. What is the year over year growth of the global Innovative Biologics and Biosimilars market?
4. What is the total value of the global Innovative Biologics and Biosimilars market?
5. Who are the major players in the global Innovative Biologics and Biosimilars market?
6. What are the growth factors driving the market demand?
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
This report studies the global Innovative Biologics and Biosimilars demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Innovative Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Innovative Biologics and Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Innovative Biologics and Biosimilars total market, 2018-2029, (USD Million)
Global Innovative Biologics and Biosimilars total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Innovative Biologics and Biosimilars total market, key domestic companies and share, (USD Million)
Global Innovative Biologics and Biosimilars revenue by player and market share 2018-2023, (USD Million)
Global Innovative Biologics and Biosimilars total market by Type, CAGR, 2018-2029, (USD Million)
Global Innovative Biologics and Biosimilars total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Innovative Biologics and Biosimilars market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Innovative Biologics and Biosimilars market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Innovative Biologics and Biosimilars Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibodies
- Interferon
- Insulin
- Vaccines
- Others
- Hospital
- Retail Pharmacy
- Other
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- Biogen
- Celltrion
- Sobi
- 3SBIO
- Changchun High Tech
- Kanghong Pharma
- Innovent Biologics
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
1. How big is the global Innovative Biologics and Biosimilars market?
2. What is the demand of the global Innovative Biologics and Biosimilars market?
3. What is the year over year growth of the global Innovative Biologics and Biosimilars market?
4. What is the total value of the global Innovative Biologics and Biosimilars market?
5. Who are the major players in the global Innovative Biologics and Biosimilars market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Innovative Biologics and Biosimilars Introduction
1.2 World Innovative Biologics and Biosimilars Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Innovative Biologics and Biosimilars Total Market by Region (by Headquarter Location)
1.3.1 World Innovative Biologics and Biosimilars Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.3 China Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.4 Europe Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.5 Japan Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.6 South Korea Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.7 ASEAN Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.8 India Innovative Biologics and Biosimilars Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Innovative Biologics and Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Innovative Biologics and Biosimilars Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.2 World Innovative Biologics and Biosimilars Consumption Value by Region
2.2.1 World Innovative Biologics and Biosimilars Consumption Value by Region (2018-2023)
2.2.2 World Innovative Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029)
2.3 United States Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.4 China Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.5 Europe Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.6 Japan Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.7 South Korea Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.8 ASEAN Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.9 India Innovative Biologics and Biosimilars Consumption Value (2018-2029)
3 WORLD INNOVATIVE BIOLOGICS AND BIOSIMILARS COMPANIES COMPETITIVE ANALYSIS
3.1 World Innovative Biologics and Biosimilars Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Innovative Biologics and Biosimilars Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Innovative Biologics and Biosimilars in 2022
3.2.3 Global Concentration Ratios (CR8) for Innovative Biologics and Biosimilars in 2022
3.3 Innovative Biologics and Biosimilars Company Evaluation Quadrant
3.4 Innovative Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.4.1 Innovative Biologics and Biosimilars Market: Region Footprint
3.4.2 Innovative Biologics and Biosimilars Market: Company Product Type Footprint
3.4.3 Innovative Biologics and Biosimilars Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Innovative Biologics and Biosimilars Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Innovative Biologics and Biosimilars Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Innovative Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Innovative Biologics and Biosimilars Consumption Value Comparison
4.2.1 United States VS China: Innovative Biologics and Biosimilars Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Innovative Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Innovative Biologics and Biosimilars Companies and Market Share, 2018-2023
4.3.1 United States Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023)
4.4 China Based Companies Innovative Biologics and Biosimilars Revenue and Market Share, 2018-2023
4.4.1 China Based Innovative Biologics and Biosimilars Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023)
4.5 Rest of World Based Innovative Biologics and Biosimilars Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Innovative Biologics and Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Interferon
5.2.3 Insulin
5.2.4 Vaccines
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Innovative Biologics and Biosimilars Market Size by Type (2018-2023)
5.3.2 World Innovative Biologics and Biosimilars Market Size by Type (2024-2029)
5.3.3 World Innovative Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Innovative Biologics and Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Innovative Biologics and Biosimilars Market Size by Application (2018-2023)
6.3.2 World Innovative Biologics and Biosimilars Market Size by Application (2024-2029)
6.3.3 World Innovative Biologics and Biosimilars Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Innovative Biologics and Biosimilars Product and Services
7.1.4 Roche Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Innovative Biologics and Biosimilars Product and Services
7.2.4 Amgen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Innovative Biologics and Biosimilars Product and Services
7.3.4 AbbVie Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Innovative Biologics and Biosimilars Product and Services
7.4.4 Sanofi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Innovative Biologics and Biosimilars Product and Services
7.5.4 Johnson & Johnson Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Innovative Biologics and Biosimilars Product and Services
7.6.4 Pfizer Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Novo Nordisk
7.7.1 Novo Nordisk Details
7.7.2 Novo Nordisk Major Business
7.7.3 Novo Nordisk Innovative Biologics and Biosimilars Product and Services
7.7.4 Novo Nordisk Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk Recent Developments/Updates
7.7.6 Novo Nordisk Competitive Strengths & Weaknesses
7.8 Eli Lilly
7.8.1 Eli Lilly Details
7.8.2 Eli Lilly Major Business
7.8.3 Eli Lilly Innovative Biologics and Biosimilars Product and Services
7.8.4 Eli Lilly Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Eli Lilly Recent Developments/Updates
7.8.6 Eli Lilly Competitive Strengths & Weaknesses
7.9 Novartis
7.9.1 Novartis Details
7.9.2 Novartis Major Business
7.9.3 Novartis Innovative Biologics and Biosimilars Product and Services
7.9.4 Novartis Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Novartis Recent Developments/Updates
7.9.6 Novartis Competitive Strengths & Weaknesses
7.10 Merck
7.10.1 Merck Details
7.10.2 Merck Major Business
7.10.3 Merck Innovative Biologics and Biosimilars Product and Services
7.10.4 Merck Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Merck Recent Developments/Updates
7.10.6 Merck Competitive Strengths & Weaknesses
7.11 Biogen
7.11.1 Biogen Details
7.11.2 Biogen Major Business
7.11.3 Biogen Innovative Biologics and Biosimilars Product and Services
7.11.4 Biogen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Biogen Recent Developments/Updates
7.11.6 Biogen Competitive Strengths & Weaknesses
7.12 Celltrion
7.12.1 Celltrion Details
7.12.2 Celltrion Major Business
7.12.3 Celltrion Innovative Biologics and Biosimilars Product and Services
7.12.4 Celltrion Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Celltrion Recent Developments/Updates
7.12.6 Celltrion Competitive Strengths & Weaknesses
7.13 Sobi
7.13.1 Sobi Details
7.13.2 Sobi Major Business
7.13.3 Sobi Innovative Biologics and Biosimilars Product and Services
7.13.4 Sobi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sobi Recent Developments/Updates
7.13.6 Sobi Competitive Strengths & Weaknesses
7.14 3SBIO
7.14.1 3SBIO Details
7.14.2 3SBIO Major Business
7.14.3 3SBIO Innovative Biologics and Biosimilars Product and Services
7.14.4 3SBIO Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 3SBIO Recent Developments/Updates
7.14.6 3SBIO Competitive Strengths & Weaknesses
7.15 Changchun High Tech
7.15.1 Changchun High Tech Details
7.15.2 Changchun High Tech Major Business
7.15.3 Changchun High Tech Innovative Biologics and Biosimilars Product and Services
7.15.4 Changchun High Tech Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Changchun High Tech Recent Developments/Updates
7.15.6 Changchun High Tech Competitive Strengths & Weaknesses
7.16 Kanghong Pharma
7.16.1 Kanghong Pharma Details
7.16.2 Kanghong Pharma Major Business
7.16.3 Kanghong Pharma Innovative Biologics and Biosimilars Product and Services
7.16.4 Kanghong Pharma Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Kanghong Pharma Recent Developments/Updates
7.16.6 Kanghong Pharma Competitive Strengths & Weaknesses
7.17 Innovent Biologics
7.17.1 Innovent Biologics Details
7.17.2 Innovent Biologics Major Business
7.17.3 Innovent Biologics Innovative Biologics and Biosimilars Product and Services
7.17.4 Innovent Biologics Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Innovent Biologics Recent Developments/Updates
7.17.6 Innovent Biologics Competitive Strengths & Weaknesses
7.18 Gan&Lee
7.18.1 Gan&Lee Details
7.18.2 Gan&Lee Major Business
7.18.3 Gan&Lee Innovative Biologics and Biosimilars Product and Services
7.18.4 Gan&Lee Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Gan&Lee Recent Developments/Updates
7.18.6 Gan&Lee Competitive Strengths & Weaknesses
7.19 Tonghua Dongbao
7.19.1 Tonghua Dongbao Details
7.19.2 Tonghua Dongbao Major Business
7.19.3 Tonghua Dongbao Innovative Biologics and Biosimilars Product and Services
7.19.4 Tonghua Dongbao Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Tonghua Dongbao Recent Developments/Updates
7.19.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.20 United Laboratory
7.20.1 United Laboratory Details
7.20.2 United Laboratory Major Business
7.20.3 United Laboratory Innovative Biologics and Biosimilars Product and Services
7.20.4 United Laboratory Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 United Laboratory Recent Developments/Updates
7.20.6 United Laboratory Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Innovative Biologics and Biosimilars Industry Chain
8.2 Innovative Biologics and Biosimilars Upstream Analysis
8.3 Innovative Biologics and Biosimilars Midstream Analysis
8.4 Innovative Biologics and Biosimilars Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Innovative Biologics and Biosimilars Introduction
1.2 World Innovative Biologics and Biosimilars Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Innovative Biologics and Biosimilars Total Market by Region (by Headquarter Location)
1.3.1 World Innovative Biologics and Biosimilars Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.3 China Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.4 Europe Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.5 Japan Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.6 South Korea Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.7 ASEAN Innovative Biologics and Biosimilars Market Size (2018-2029)
1.3.8 India Innovative Biologics and Biosimilars Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Innovative Biologics and Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Innovative Biologics and Biosimilars Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.2 World Innovative Biologics and Biosimilars Consumption Value by Region
2.2.1 World Innovative Biologics and Biosimilars Consumption Value by Region (2018-2023)
2.2.2 World Innovative Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029)
2.3 United States Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.4 China Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.5 Europe Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.6 Japan Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.7 South Korea Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.8 ASEAN Innovative Biologics and Biosimilars Consumption Value (2018-2029)
2.9 India Innovative Biologics and Biosimilars Consumption Value (2018-2029)
3 WORLD INNOVATIVE BIOLOGICS AND BIOSIMILARS COMPANIES COMPETITIVE ANALYSIS
3.1 World Innovative Biologics and Biosimilars Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Innovative Biologics and Biosimilars Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Innovative Biologics and Biosimilars in 2022
3.2.3 Global Concentration Ratios (CR8) for Innovative Biologics and Biosimilars in 2022
3.3 Innovative Biologics and Biosimilars Company Evaluation Quadrant
3.4 Innovative Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.4.1 Innovative Biologics and Biosimilars Market: Region Footprint
3.4.2 Innovative Biologics and Biosimilars Market: Company Product Type Footprint
3.4.3 Innovative Biologics and Biosimilars Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Innovative Biologics and Biosimilars Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Innovative Biologics and Biosimilars Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Innovative Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Innovative Biologics and Biosimilars Consumption Value Comparison
4.2.1 United States VS China: Innovative Biologics and Biosimilars Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Innovative Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Innovative Biologics and Biosimilars Companies and Market Share, 2018-2023
4.3.1 United States Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023)
4.4 China Based Companies Innovative Biologics and Biosimilars Revenue and Market Share, 2018-2023
4.4.1 China Based Innovative Biologics and Biosimilars Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023)
4.5 Rest of World Based Innovative Biologics and Biosimilars Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Innovative Biologics and Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Interferon
5.2.3 Insulin
5.2.4 Vaccines
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Innovative Biologics and Biosimilars Market Size by Type (2018-2023)
5.3.2 World Innovative Biologics and Biosimilars Market Size by Type (2024-2029)
5.3.3 World Innovative Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Innovative Biologics and Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Innovative Biologics and Biosimilars Market Size by Application (2018-2023)
6.3.2 World Innovative Biologics and Biosimilars Market Size by Application (2024-2029)
6.3.3 World Innovative Biologics and Biosimilars Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Innovative Biologics and Biosimilars Product and Services
7.1.4 Roche Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Innovative Biologics and Biosimilars Product and Services
7.2.4 Amgen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Innovative Biologics and Biosimilars Product and Services
7.3.4 AbbVie Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Innovative Biologics and Biosimilars Product and Services
7.4.4 Sanofi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Innovative Biologics and Biosimilars Product and Services
7.5.4 Johnson & Johnson Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Innovative Biologics and Biosimilars Product and Services
7.6.4 Pfizer Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Novo Nordisk
7.7.1 Novo Nordisk Details
7.7.2 Novo Nordisk Major Business
7.7.3 Novo Nordisk Innovative Biologics and Biosimilars Product and Services
7.7.4 Novo Nordisk Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk Recent Developments/Updates
7.7.6 Novo Nordisk Competitive Strengths & Weaknesses
7.8 Eli Lilly
7.8.1 Eli Lilly Details
7.8.2 Eli Lilly Major Business
7.8.3 Eli Lilly Innovative Biologics and Biosimilars Product and Services
7.8.4 Eli Lilly Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Eli Lilly Recent Developments/Updates
7.8.6 Eli Lilly Competitive Strengths & Weaknesses
7.9 Novartis
7.9.1 Novartis Details
7.9.2 Novartis Major Business
7.9.3 Novartis Innovative Biologics and Biosimilars Product and Services
7.9.4 Novartis Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Novartis Recent Developments/Updates
7.9.6 Novartis Competitive Strengths & Weaknesses
7.10 Merck
7.10.1 Merck Details
7.10.2 Merck Major Business
7.10.3 Merck Innovative Biologics and Biosimilars Product and Services
7.10.4 Merck Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Merck Recent Developments/Updates
7.10.6 Merck Competitive Strengths & Weaknesses
7.11 Biogen
7.11.1 Biogen Details
7.11.2 Biogen Major Business
7.11.3 Biogen Innovative Biologics and Biosimilars Product and Services
7.11.4 Biogen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Biogen Recent Developments/Updates
7.11.6 Biogen Competitive Strengths & Weaknesses
7.12 Celltrion
7.12.1 Celltrion Details
7.12.2 Celltrion Major Business
7.12.3 Celltrion Innovative Biologics and Biosimilars Product and Services
7.12.4 Celltrion Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Celltrion Recent Developments/Updates
7.12.6 Celltrion Competitive Strengths & Weaknesses
7.13 Sobi
7.13.1 Sobi Details
7.13.2 Sobi Major Business
7.13.3 Sobi Innovative Biologics and Biosimilars Product and Services
7.13.4 Sobi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sobi Recent Developments/Updates
7.13.6 Sobi Competitive Strengths & Weaknesses
7.14 3SBIO
7.14.1 3SBIO Details
7.14.2 3SBIO Major Business
7.14.3 3SBIO Innovative Biologics and Biosimilars Product and Services
7.14.4 3SBIO Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 3SBIO Recent Developments/Updates
7.14.6 3SBIO Competitive Strengths & Weaknesses
7.15 Changchun High Tech
7.15.1 Changchun High Tech Details
7.15.2 Changchun High Tech Major Business
7.15.3 Changchun High Tech Innovative Biologics and Biosimilars Product and Services
7.15.4 Changchun High Tech Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Changchun High Tech Recent Developments/Updates
7.15.6 Changchun High Tech Competitive Strengths & Weaknesses
7.16 Kanghong Pharma
7.16.1 Kanghong Pharma Details
7.16.2 Kanghong Pharma Major Business
7.16.3 Kanghong Pharma Innovative Biologics and Biosimilars Product and Services
7.16.4 Kanghong Pharma Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Kanghong Pharma Recent Developments/Updates
7.16.6 Kanghong Pharma Competitive Strengths & Weaknesses
7.17 Innovent Biologics
7.17.1 Innovent Biologics Details
7.17.2 Innovent Biologics Major Business
7.17.3 Innovent Biologics Innovative Biologics and Biosimilars Product and Services
7.17.4 Innovent Biologics Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Innovent Biologics Recent Developments/Updates
7.17.6 Innovent Biologics Competitive Strengths & Weaknesses
7.18 Gan&Lee
7.18.1 Gan&Lee Details
7.18.2 Gan&Lee Major Business
7.18.3 Gan&Lee Innovative Biologics and Biosimilars Product and Services
7.18.4 Gan&Lee Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Gan&Lee Recent Developments/Updates
7.18.6 Gan&Lee Competitive Strengths & Weaknesses
7.19 Tonghua Dongbao
7.19.1 Tonghua Dongbao Details
7.19.2 Tonghua Dongbao Major Business
7.19.3 Tonghua Dongbao Innovative Biologics and Biosimilars Product and Services
7.19.4 Tonghua Dongbao Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Tonghua Dongbao Recent Developments/Updates
7.19.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.20 United Laboratory
7.20.1 United Laboratory Details
7.20.2 United Laboratory Major Business
7.20.3 United Laboratory Innovative Biologics and Biosimilars Product and Services
7.20.4 United Laboratory Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 United Laboratory Recent Developments/Updates
7.20.6 United Laboratory Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Innovative Biologics and Biosimilars Industry Chain
8.2 Innovative Biologics and Biosimilars Upstream Analysis
8.3 Innovative Biologics and Biosimilars Midstream Analysis
8.4 Innovative Biologics and Biosimilars Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Innovative Biologics and Biosimilars Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Innovative Biologics and Biosimilars Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Innovative Biologics and Biosimilars Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Innovative Biologics and Biosimilars Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Innovative Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Innovative Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Innovative Biologics and Biosimilars Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Innovative Biologics and Biosimilars Players in 2022
Table 12. World Innovative Biologics and Biosimilars Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Innovative Biologics and Biosimilars Company Evaluation Quadrant
Table 14. Head Office of Key Innovative Biologics and Biosimilars Player
Table 15. Innovative Biologics and Biosimilars Market: Company Product Type Footprint
Table 16. Innovative Biologics and Biosimilars Market: Company Product Application Footprint
Table 17. Innovative Biologics and Biosimilars Mergers & Acquisitions Activity
Table 18. United States VS China Innovative Biologics and Biosimilars Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Innovative Biologics and Biosimilars Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 21. United States Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Innovative Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 23. China Based Innovative Biologics and Biosimilars Companies, Headquarters (Province, Country)
Table 24. China Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Innovative Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 26. Rest of World Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Innovative Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 29. World Innovative Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Innovative Biologics and Biosimilars Market Size by Type (2018-2023) & (USD Million)
Table 31. World Innovative Biologics and Biosimilars Market Size by Type (2024-2029) & (USD Million)
Table 32. World Innovative Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Innovative Biologics and Biosimilars Market Size by Application (2018-2023) & (USD Million)
Table 34. World Innovative Biologics and Biosimilars Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Innovative Biologics and Biosimilars Product and Services
Table 38. Roche Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Innovative Biologics and Biosimilars Product and Services
Table 44. Amgen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Innovative Biologics and Biosimilars Product and Services
Table 50. AbbVie Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Sanofi Basic Information, Area Served and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Innovative Biologics and Biosimilars Product and Services
Table 56. Sanofi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sanofi Recent Developments/Updates
Table 58. Sanofi Competitive Strengths & Weaknesses
Table 59. Johnson & Johnson Basic Information, Area Served and Competitors
Table 60. Johnson & Johnson Major Business
Table 61. Johnson & Johnson Innovative Biologics and Biosimilars Product and Services
Table 62. Johnson & Johnson Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Johnson & Johnson Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Innovative Biologics and Biosimilars Product and Services
Table 68. Pfizer Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Novo Nordisk Basic Information, Area Served and Competitors
Table 72. Novo Nordisk Major Business
Table 73. Novo Nordisk Innovative Biologics and Biosimilars Product and Services
Table 74. Novo Nordisk Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novo Nordisk Recent Developments/Updates
Table 76. Novo Nordisk Competitive Strengths & Weaknesses
Table 77. Eli Lilly Basic Information, Area Served and Competitors
Table 78. Eli Lilly Major Business
Table 79. Eli Lilly Innovative Biologics and Biosimilars Product and Services
Table 80. Eli Lilly Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Eli Lilly Recent Developments/Updates
Table 82. Eli Lilly Competitive Strengths & Weaknesses
Table 83. Novartis Basic Information, Area Served and Competitors
Table 84. Novartis Major Business
Table 85. Novartis Innovative Biologics and Biosimilars Product and Services
Table 86. Novartis Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Novartis Recent Developments/Updates
Table 88. Novartis Competitive Strengths & Weaknesses
Table 89. Merck Basic Information, Area Served and Competitors
Table 90. Merck Major Business
Table 91. Merck Innovative Biologics and Biosimilars Product and Services
Table 92. Merck Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Merck Recent Developments/Updates
Table 94. Merck Competitive Strengths & Weaknesses
Table 95. Biogen Basic Information, Area Served and Competitors
Table 96. Biogen Major Business
Table 97. Biogen Innovative Biologics and Biosimilars Product and Services
Table 98. Biogen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Biogen Recent Developments/Updates
Table 100. Biogen Competitive Strengths & Weaknesses
Table 101. Celltrion Basic Information, Area Served and Competitors
Table 102. Celltrion Major Business
Table 103. Celltrion Innovative Biologics and Biosimilars Product and Services
Table 104. Celltrion Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Celltrion Recent Developments/Updates
Table 106. Celltrion Competitive Strengths & Weaknesses
Table 107. Sobi Basic Information, Area Served and Competitors
Table 108. Sobi Major Business
Table 109. Sobi Innovative Biologics and Biosimilars Product and Services
Table 110. Sobi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Sobi Recent Developments/Updates
Table 112. Sobi Competitive Strengths & Weaknesses
Table 113. 3SBIO Basic Information, Area Served and Competitors
Table 114. 3SBIO Major Business
Table 115. 3SBIO Innovative Biologics and Biosimilars Product and Services
Table 116. 3SBIO Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. 3SBIO Recent Developments/Updates
Table 118. 3SBIO Competitive Strengths & Weaknesses
Table 119. Changchun High Tech Basic Information, Area Served and Competitors
Table 120. Changchun High Tech Major Business
Table 121. Changchun High Tech Innovative Biologics and Biosimilars Product and Services
Table 122. Changchun High Tech Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Changchun High Tech Recent Developments/Updates
Table 124. Changchun High Tech Competitive Strengths & Weaknesses
Table 125. Kanghong Pharma Basic Information, Area Served and Competitors
Table 126. Kanghong Pharma Major Business
Table 127. Kanghong Pharma Innovative Biologics and Biosimilars Product and Services
Table 128. Kanghong Pharma Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Kanghong Pharma Recent Developments/Updates
Table 130. Kanghong Pharma Competitive Strengths & Weaknesses
Table 131. Innovent Biologics Basic Information, Area Served and Competitors
Table 132. Innovent Biologics Major Business
Table 133. Innovent Biologics Innovative Biologics and Biosimilars Product and Services
Table 134. Innovent Biologics Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Innovent Biologics Recent Developments/Updates
Table 136. Innovent Biologics Competitive Strengths & Weaknesses
Table 137. Gan&Lee Basic Information, Area Served and Competitors
Table 138. Gan&Lee Major Business
Table 139. Gan&Lee Innovative Biologics and Biosimilars Product and Services
Table 140. Gan&Lee Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Gan&Lee Recent Developments/Updates
Table 142. Gan&Lee Competitive Strengths & Weaknesses
Table 143. Tonghua Dongbao Basic Information, Area Served and Competitors
Table 144. Tonghua Dongbao Major Business
Table 145. Tonghua Dongbao Innovative Biologics and Biosimilars Product and Services
Table 146. Tonghua Dongbao Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Tonghua Dongbao Recent Developments/Updates
Table 148. United Laboratory Basic Information, Area Served and Competitors
Table 149. United Laboratory Major Business
Table 150. United Laboratory Innovative Biologics and Biosimilars Product and Services
Table 151. United Laboratory Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Innovative Biologics and Biosimilars Upstream (Raw Materials)
Table 153. Innovative Biologics and Biosimilars Typical Customers
Table 1. World Innovative Biologics and Biosimilars Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Innovative Biologics and Biosimilars Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Innovative Biologics and Biosimilars Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Innovative Biologics and Biosimilars Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Innovative Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Innovative Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Innovative Biologics and Biosimilars Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Innovative Biologics and Biosimilars Players in 2022
Table 12. World Innovative Biologics and Biosimilars Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Innovative Biologics and Biosimilars Company Evaluation Quadrant
Table 14. Head Office of Key Innovative Biologics and Biosimilars Player
Table 15. Innovative Biologics and Biosimilars Market: Company Product Type Footprint
Table 16. Innovative Biologics and Biosimilars Market: Company Product Application Footprint
Table 17. Innovative Biologics and Biosimilars Mergers & Acquisitions Activity
Table 18. United States VS China Innovative Biologics and Biosimilars Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Innovative Biologics and Biosimilars Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 21. United States Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Innovative Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 23. China Based Innovative Biologics and Biosimilars Companies, Headquarters (Province, Country)
Table 24. China Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Innovative Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 26. Rest of World Based Innovative Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Innovative Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Innovative Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 29. World Innovative Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Innovative Biologics and Biosimilars Market Size by Type (2018-2023) & (USD Million)
Table 31. World Innovative Biologics and Biosimilars Market Size by Type (2024-2029) & (USD Million)
Table 32. World Innovative Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Innovative Biologics and Biosimilars Market Size by Application (2018-2023) & (USD Million)
Table 34. World Innovative Biologics and Biosimilars Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Innovative Biologics and Biosimilars Product and Services
Table 38. Roche Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Innovative Biologics and Biosimilars Product and Services
Table 44. Amgen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Innovative Biologics and Biosimilars Product and Services
Table 50. AbbVie Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Sanofi Basic Information, Area Served and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Innovative Biologics and Biosimilars Product and Services
Table 56. Sanofi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sanofi Recent Developments/Updates
Table 58. Sanofi Competitive Strengths & Weaknesses
Table 59. Johnson & Johnson Basic Information, Area Served and Competitors
Table 60. Johnson & Johnson Major Business
Table 61. Johnson & Johnson Innovative Biologics and Biosimilars Product and Services
Table 62. Johnson & Johnson Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Johnson & Johnson Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Innovative Biologics and Biosimilars Product and Services
Table 68. Pfizer Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Novo Nordisk Basic Information, Area Served and Competitors
Table 72. Novo Nordisk Major Business
Table 73. Novo Nordisk Innovative Biologics and Biosimilars Product and Services
Table 74. Novo Nordisk Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novo Nordisk Recent Developments/Updates
Table 76. Novo Nordisk Competitive Strengths & Weaknesses
Table 77. Eli Lilly Basic Information, Area Served and Competitors
Table 78. Eli Lilly Major Business
Table 79. Eli Lilly Innovative Biologics and Biosimilars Product and Services
Table 80. Eli Lilly Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Eli Lilly Recent Developments/Updates
Table 82. Eli Lilly Competitive Strengths & Weaknesses
Table 83. Novartis Basic Information, Area Served and Competitors
Table 84. Novartis Major Business
Table 85. Novartis Innovative Biologics and Biosimilars Product and Services
Table 86. Novartis Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Novartis Recent Developments/Updates
Table 88. Novartis Competitive Strengths & Weaknesses
Table 89. Merck Basic Information, Area Served and Competitors
Table 90. Merck Major Business
Table 91. Merck Innovative Biologics and Biosimilars Product and Services
Table 92. Merck Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Merck Recent Developments/Updates
Table 94. Merck Competitive Strengths & Weaknesses
Table 95. Biogen Basic Information, Area Served and Competitors
Table 96. Biogen Major Business
Table 97. Biogen Innovative Biologics and Biosimilars Product and Services
Table 98. Biogen Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Biogen Recent Developments/Updates
Table 100. Biogen Competitive Strengths & Weaknesses
Table 101. Celltrion Basic Information, Area Served and Competitors
Table 102. Celltrion Major Business
Table 103. Celltrion Innovative Biologics and Biosimilars Product and Services
Table 104. Celltrion Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Celltrion Recent Developments/Updates
Table 106. Celltrion Competitive Strengths & Weaknesses
Table 107. Sobi Basic Information, Area Served and Competitors
Table 108. Sobi Major Business
Table 109. Sobi Innovative Biologics and Biosimilars Product and Services
Table 110. Sobi Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Sobi Recent Developments/Updates
Table 112. Sobi Competitive Strengths & Weaknesses
Table 113. 3SBIO Basic Information, Area Served and Competitors
Table 114. 3SBIO Major Business
Table 115. 3SBIO Innovative Biologics and Biosimilars Product and Services
Table 116. 3SBIO Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. 3SBIO Recent Developments/Updates
Table 118. 3SBIO Competitive Strengths & Weaknesses
Table 119. Changchun High Tech Basic Information, Area Served and Competitors
Table 120. Changchun High Tech Major Business
Table 121. Changchun High Tech Innovative Biologics and Biosimilars Product and Services
Table 122. Changchun High Tech Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Changchun High Tech Recent Developments/Updates
Table 124. Changchun High Tech Competitive Strengths & Weaknesses
Table 125. Kanghong Pharma Basic Information, Area Served and Competitors
Table 126. Kanghong Pharma Major Business
Table 127. Kanghong Pharma Innovative Biologics and Biosimilars Product and Services
Table 128. Kanghong Pharma Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Kanghong Pharma Recent Developments/Updates
Table 130. Kanghong Pharma Competitive Strengths & Weaknesses
Table 131. Innovent Biologics Basic Information, Area Served and Competitors
Table 132. Innovent Biologics Major Business
Table 133. Innovent Biologics Innovative Biologics and Biosimilars Product and Services
Table 134. Innovent Biologics Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Innovent Biologics Recent Developments/Updates
Table 136. Innovent Biologics Competitive Strengths & Weaknesses
Table 137. Gan&Lee Basic Information, Area Served and Competitors
Table 138. Gan&Lee Major Business
Table 139. Gan&Lee Innovative Biologics and Biosimilars Product and Services
Table 140. Gan&Lee Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Gan&Lee Recent Developments/Updates
Table 142. Gan&Lee Competitive Strengths & Weaknesses
Table 143. Tonghua Dongbao Basic Information, Area Served and Competitors
Table 144. Tonghua Dongbao Major Business
Table 145. Tonghua Dongbao Innovative Biologics and Biosimilars Product and Services
Table 146. Tonghua Dongbao Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Tonghua Dongbao Recent Developments/Updates
Table 148. United Laboratory Basic Information, Area Served and Competitors
Table 149. United Laboratory Major Business
Table 150. United Laboratory Innovative Biologics and Biosimilars Product and Services
Table 151. United Laboratory Innovative Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Innovative Biologics and Biosimilars Upstream (Raw Materials)
Table 153. Innovative Biologics and Biosimilars Typical Customers
LIST OF FIGURES
Figure 1. Innovative Biologics and Biosimilars Picture
Figure 2. World Innovative Biologics and Biosimilars Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Innovative Biologics and Biosimilars Total Market Size (2018-2029) & (USD Million)
Figure 4. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 13. Innovative Biologics and Biosimilars Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 16. World Innovative Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 18. China Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 23. India Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Innovative Biologics and Biosimilars by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Innovative Biologics and Biosimilars Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Innovative Biologics and Biosimilars Markets in 2022
Figure 27. United States VS China: Innovative Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Innovative Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Innovative Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Innovative Biologics and Biosimilars Market Size Market Share by Type in 2022
Figure 31. Monoclonal Antibodies
Figure 32. Interferon
Figure 33. Insulin
Figure 34. Vaccines
Figure 35. Others
Figure 36. World Innovative Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
Figure 37. World Innovative Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Innovative Biologics and Biosimilars Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Retail Pharmacy
Figure 41. Other
Figure 42. Innovative Biologics and Biosimilars Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Innovative Biologics and Biosimilars Picture
Figure 2. World Innovative Biologics and Biosimilars Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Innovative Biologics and Biosimilars Total Market Size (2018-2029) & (USD Million)
Figure 4. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Innovative Biologics and Biosimilars Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Innovative Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 13. Innovative Biologics and Biosimilars Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 16. World Innovative Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 18. China Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 23. India Innovative Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Innovative Biologics and Biosimilars by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Innovative Biologics and Biosimilars Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Innovative Biologics and Biosimilars Markets in 2022
Figure 27. United States VS China: Innovative Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Innovative Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Innovative Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Innovative Biologics and Biosimilars Market Size Market Share by Type in 2022
Figure 31. Monoclonal Antibodies
Figure 32. Interferon
Figure 33. Insulin
Figure 34. Vaccines
Figure 35. Others
Figure 36. World Innovative Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
Figure 37. World Innovative Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Innovative Biologics and Biosimilars Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Retail Pharmacy
Figure 41. Other
Figure 42. Innovative Biologics and Biosimilars Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
